Genesco Inc. reported GAAP earnings from continuing operations per diluted share of $0.37 for the three months ended April 30, 2022. Net sales decreased 3% to $521 million. The company reaffirmed its Fiscal 2023 full year EPS guidance.
Net sales decreased by 3% year-over-year to $521 million, but increased 5% over Q1FY20.
Gross margin increased 50 basis points compared to the previous year.
GAAP operating income decreased 47% from last year.
Non-GAAP EPS from continuing operations was $0.441, compared to $0.79 last year.
The Company reaffirms its Fiscal 2023 full year EPS guidance. Adjusted diluted earnings per share from continuing operations in the range of $7.00 to $7.75, with an expectation that earnings per share for the year will be near the mid-point of the range.
Visualization of income flow from segment revenue to net income